White blood cell and platelet distribution widths are associated with hypertension: data mining approaches.
Decision tree
Hematology
Hypertension
Logistic regression
Journal
Hypertension research : official journal of the Japanese Society of Hypertension
ISSN: 1348-4214
Titre abrégé: Hypertens Res
Pays: England
ID NLM: 9307690
Informations de publication
Date de publication:
25 Oct 2023
25 Oct 2023
Historique:
received:
23
01
2023
accepted:
27
09
2023
revised:
23
09
2023
pubmed:
26
10
2023
medline:
26
10
2023
entrez:
25
10
2023
Statut:
aheadofprint
Résumé
In this paper, we are going to investigate the association between Hypertension (HTN) and routine hematologic indices in a cohort of Iranian adults. The data were obtained from a total population of 9704 who were aged 35-65 years, a prospective study was designed. The association between hematologic factors and HTN was assessed using logistic regression (LR) analysis and a decision tree (DT) algorithm. A total of 9704 complete datasets were analyzed in this cohort study (N = 3070 with HTN [female 62.47% and male 37.52%], N = 6634 without HTN [female 58.90% and male 41.09%]). Several variables were significantly different between the two groups, including age, smoking status, BMI, diabetes millitus, high sensitivity C-reactive protein (hs-CRP), uric acid, FBS, total cholesterol, HGB, LYM, WBC, PDW, RDW, RBC, sex, PLT, MCV, SBP, DBP, BUN, and HCT (P < 0.05). For unit odds ratio (OR) interpretation, females are more likely to have HTN (OR = 1.837, 95% CI = (1.620, 2.081)). Among the analyzed variables, age and WBC had the most significant associations with HTN OR = 1.087, 95% CI = (1.081, 1.094) and OR = 1.096, 95% CI = (1.061, 1.133), respectively (P-value < 0.05). In the DT model, age, followed by WBC, sex, and PDW, has the most significant impact on the HTN risk. Ninety-eight percent of patients had HTN in the subgroup with older age (≥58), high PDW (≥17.3), and low RDW (<46). Finally, we found that elevated WBC and PDW are the most associated factor with the severity of HTN in the Mashhad general population as well as female gender and older age.
Identifiants
pubmed: 37880498
doi: 10.1038/s41440-023-01472-y
pii: 10.1038/s41440-023-01472-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2023. The Author(s), under exclusive licence to The Japanese Society of Hypertension.
Références
GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1923–94.
doi: 10.1016/S0140-6736(18)32225-6
GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–88.
doi: 10.1016/S0140-6736(18)32203-7
Tayefi M, Shabani N, Saberi-Karimian M, Oladi M, Mouhebati M, Farjami Z, et al. Systolic and diastolic blood pressure percentiles by age and gender in Northeastern Iran. J Am Soc Hypertens. 2018;12:e85–91.
pubmed: 30509778
doi: 10.1016/j.jash.2018.11.003
Flack JM, Adekola B. Blood pressure and the new ACC/AHA hypertension guidelines. Trends Cardiovasc Med. 2020;30:160–4.
pubmed: 31521481
doi: 10.1016/j.tcm.2019.05.003
Aghasizadeh M, Samadi S, Sahebkar A, Miri‐Moghaddam E, Esmaily H, Souktanloo M, et al. Serum HDL cholesterol uptake capacity in subjects from the MASHAD cohort study: Its value in determining the risk of cardiovascular endpoints. J Clin Lab Anal. 2021;35:e23770.
pubmed: 34028874
pmcid: 8183926
doi: 10.1002/jcla.23770
Fakhri M, Sarokhani D, Ghiasi B, Dehkordi AH. Prevalence of hypertension in cardiovascular disease in iran: systematic review and meta-analysis. Int J Prev Med. 2020;11:56.
pubmed: 32577186
pmcid: 7297428
Shrestha PL, Shrestha PA, Vivo RP. Epidemiology of comorbidities in patients with hypertension. Curr Opin Cardiol. 2016;31:376–80.
pubmed: 27137759
doi: 10.1097/HCO.0000000000000298
Aghasizadeh M, Bizhaem SK, Baniasadi M, Khazdair MR, Kazemi T. Evaluation of LDL goal achievement in statin consumption, south east of Iran. Sci Rep. 2021;11:1–8.
doi: 10.1038/s41598-021-90228-0
Ishida S, Kondo S, Funakoshi S, Satoh A, Maeda T, Kawazoe M, et al. White blood cell count and incidence of hypertension in the general Japanese population: ISSA-CKD study. PLoS One. 2021;16:e0246304.
pubmed: 33529192
pmcid: 7853436
doi: 10.1371/journal.pone.0246304
Jeong HR, Shim YS, Lee HS, Hwang JS. Hemoglobin and hematocrit levels are positively associated with blood pressure in children and adolescents 10 to 18 years old. Sci Rep. 2021;11:19052.
pubmed: 34561491
pmcid: 8463603
doi: 10.1038/s41598-021-98472-0
Kim NH, Lee JM, Kim HC, Lee JY, Yeom H, Lee JH, et al. Cross-sectional and longitudinal association between hemoglobin concentration and hypertension: a population-based cohort study. Medicine. 2016;95:e5041.
pubmed: 27741113
pmcid: 5072940
doi: 10.1097/MD.0000000000005041
Lee SG, Rim JH, Kim JH. Association of hemoglobin levels with blood pressure and hypertension in a large population-based study: the Korea National Health and Nutrition Examination Surveys 2008-2011. Clin Chim Acta. 2015;438:12–8.
pubmed: 25108209
doi: 10.1016/j.cca.2014.07.041
Atsma F, Veldhuizen I, de Kort W, van Kraaij M, Pasker-de Jong P, Deinum J. Hemoglobin level is positively associated with blood pressure in a large cohort of healthy individuals. Hypertension. 2012;60:936–41.
pubmed: 22949533
doi: 10.1161/HYPERTENSIONAHA.112.193565
Liu X, Liang J, Qiu Q, Zhu Y, Sun Y, Ying P, et al. Association of hematocrit and pre-hypertension among Chinese adults: the CRC study. Cell Biochem Biophys. 2015;71:1123–8.
pubmed: 25476140
doi: 10.1007/s12013-014-0318-5
Paul L, Jeemon P, Hewitt J, McCallum L, Higgins P, Walters M, et al. Hematocrit predicts long-term mortality in a nonlinear and sex-specific manner in hypertensive adults. Hypertension. 2012;60:631–8.
pubmed: 22802225
doi: 10.1161/HYPERTENSIONAHA.112.191510
Pusuroglu H, Akgul O, Erturk M, Surgit O, Tasbulak O, Akkaya E, et al. Red cell distribution width and end-organ damage in patients with systo-diastolic hypertension. Arch Med Sci. 2016;12:319–25.
pubmed: 27186175
pmcid: 4848362
doi: 10.5114/aoms.2016.59257
Emamian M, Hasanian SM, Tayefi M, Bijari M, Movahedian Far F, Shafiee M, et al. Association of hematocrit with blood pressure and hypertension. J Clin Lab Anal. 2017;31:e22124.
pubmed: 28105697
pmcid: 6816830
doi: 10.1002/jcla.22124
Merad-Boudia HN, Dali-Sahi M, Kachekouche Y, Dennouni-Medjati N. Hematologic disorders during essential hypertension. Diabetes Metab Syndr. 2019;13:1575–9.
pubmed: 31336524
doi: 10.1016/j.dsx.2019.03.011
Gang L, Yanyan Z, Zhongwei Z, Juan D. Association between mean platelet volume and hypertension incidence. Hypertens Res. 2017;40:779–84.
pubmed: 28275234
doi: 10.1038/hr.2017.30
Pusuroglu H, Cizgici AY, Demir AR, Uygur B, Ozal E. Long-term prognostic value of mean platelet volume in patients with hypertension. Acta Cardiol Sin. 2021;37:504–11.
pubmed: 34584383
pmcid: 8414073
Akın H, Bilge Ö, Yavuz B, Özkan S, Işık F. The relationship between mean platelet volume and resistant hypertension. Clin Exp Hypertens. 2022;44:228–32.
pubmed: 34974786
doi: 10.1080/10641963.2021.2022686
Zhan YL, Zou B, Kang T, Xiong LB, Zou J, Wei YF. Multiplicative interaction between mean corpuscular volume and red cell distribution width with target organ damage in hypertensive patients. J Clin Lab Anal. 2017;31:e22082.
pubmed: 27735087
doi: 10.1002/jcla.22082
Lin S, Zhang L, Shen S, Wei D, Lu J, Chen X, et al. Platelet parameters and risk of hypertension disorders of pregnancy: a propensity score adjusted analysis. Platelets. 2022;33:543–50.
pubmed: 34223796
doi: 10.1080/09537104.2021.1945569
Li T, Jin J, Meng Z, Zhang W, Li Y, Yu X, et al. The different associations between platelet distribution width and hypertension subtypes in males and females. Biosci Rep. 2020;40:BSR20201747.
pubmed: 33146715
pmcid: 7677823
doi: 10.1042/BSR20201747
Anderson GH. Effect of age on hypertension: analysis of over 4,800 referred hypertensive patients. Saudi J Kidney Dis Transplant. 1999;10:286.
McEniery CM, Wilkinson IB, Avolio AP. Age, hypertension and arterial function. Clin Exp Pharmacol Physiol. 2007;34:665–71.
pubmed: 17581227
doi: 10.1111/j.1440-1681.2007.04657.x
Gillis EE, Sullivan JC. Sex differences in hypertension: recent advances. Hypertension. 2016;68:1322–7.
pubmed: 27777357
doi: 10.1161/HYPERTENSIONAHA.116.06602
Connelly PJ, Currie G, Delles C. Sex differences in the prevalence, outcomes and management of hypertension. Curr Hypertens Rep. 2022;24:185–92.
pubmed: 35254589
pmcid: 9239955
doi: 10.1007/s11906-022-01183-8
Gilstrap LG, Wang TJ. Biomarkers and cardiovascular risk assessment for primary prevention: an update. Clin Chem. 2012;58:72–82.
pubmed: 22125305
doi: 10.1373/clinchem.2011.165712
den Engelsen C, Koekkoek PS, Gorter KJ, van den Donk M, Salomé PL, Rutten GE. High-sensitivity C-reactive protein to detect metabolic syndrome in a centrally obese population: a cross-sectional analysis. Cardiovasc Diabetol. 2012;11:1–7.
Shah T, Newcombe P, Smeeth L, Addo J, Casas JP, Whittaker J, et al. Ancestry as a determinant of mean population C-reactive protein values: implications for cardiovascular risk prediction. Circulation. 2010;3:436–44.
pubmed: 20876875
Deo RC. Machine learning in medicine. Circulation. 2015;132:1920–30.
pubmed: 26572668
pmcid: 5831252
doi: 10.1161/CIRCULATIONAHA.115.001593
Saberi‐Karimian M, Safarian‐Bana H, Mohammadzadeh E, Kazemi T, Mansoori A, Ghazizadeh H, et al. A pilot study of the effects of crocin on high‐density lipoprotein cholesterol uptake capacity in patients with metabolic syndrome: a randomized clinical trial. BioFactors. 2021;47:1032–41.
pubmed: 34609029
doi: 10.1002/biof.1783
Mahesh B. Machine learning algorithms -a review. International Journal of Science and Research. 2020;9:381–6.
Ghayour-Mobarhan M, Moohebati M, Esmaily H, Ebrahimi M, Parizadeh SMR, Heidari-Bakavoli AR, et al. Mashhad stroke and heart atherosclerotic disorder (MASHAD) study: design, baseline characteristics and 10-year cardiovascular risk estimation. Int J Public Health. 2015;60:561–72.
pubmed: 25943424
doi: 10.1007/s00038-015-0679-6
Hosmer Jr DW, Lemeshow S, Sturdivant RX. Applied logistic regression. 3rd ed. Hoboken, NJ: John Wiley & Sons; 2013.
Hooley JM, Teasdale JD. Predictors of relapse in unipolar depressives: expressed emotion, marital distress, and perceived criticism. J Abnorm Psychol. 1989;98:229.
pubmed: 2768657
doi: 10.1037/0021-843X.98.3.229
Mohammadi F, Pourzamani H, Karimi H, Mohammadi M, Mohammadi M, Ardalan N, et al. Artificial neural network and logistic regression modelling to characterize COVID-19 infected patients in local areas of Iran. Biomed J. 2021;44:304–16.
pubmed: 34127421
pmcid: 7905378
doi: 10.1016/j.bj.2021.02.006
Saberi-Karimian M, Khorasanchi Z, Ghazizadeh H, Tayefi M, Saffar S, Ferns GA, et al. Potential value and impact of data mining and machine learning in clinical diagnostics. Crit Rev Clin Lab Sci. 2021;58:275–96.
pubmed: 33739235
doi: 10.1080/10408363.2020.1857681
Mohammadi M, Mansoori A. A projection neural network for identifying copy number variants. IEEE J Biomed health Inform. 2018;23:2182–8.
pubmed: 30235154
doi: 10.1109/JBHI.2018.2871619
The analysis of cases based on decision tree. In Zhong Y, editor. 7th IEEE international conference on software engineering and service science (ICSESS). Beijing: IEEE; 2016.
Mansoori A, Sahranavard T, Hosseini ZS, Soflaei SS, Emrani N, Nazar E, et al. Prediction of type 2 diabetes mellitus using hematological factors based on machine learning approaches: a cohort study analysis. Sci Rep. 2023;13:1–11.
doi: 10.1038/s41598-022-27340-2
Saberi‐Karimian M, Mansoori A, Bajgiran MM, Hosseini ZS, Kiyoumarsioskouei A, Rad ES, et al. Data mining approaches for type 2 diabetes mellitus prediction using anthropometric measurements. J Clin Lab Anal. 2023;37:e24798.
pubmed: 36510349
pmcid: 9833979
doi: 10.1002/jcla.24798
Mansoori A, Hosseini ZS, Ahari RK, Poudineh M, Rad ES, Zo MM, et al. Development of data mining algorithms for identifying the best anthropometric predictors for cardiovascular disease: MASHAD cohort study. High Blood Press Cardiovasc Prev. 2023;30:243–53.
pubmed: 37204657
doi: 10.1007/s40292-023-00577-2
Ghazizadeh H, Shakour N, Ghoflchi S, Mansoori A, Saberi-Karimiam M, Rashidmayvan M, et al. Use of data mining approaches to explore the association between type 2 diabetes mellitus with SARS-CoV-2. BMC Pulm Med. 2023;23:1–14.
doi: 10.1186/s12890-023-02495-4
Wu S, Jin C, Li S, Zheng X, Zhang X, Cui L, et al. Aging, arterial stiffness, and blood pressure association in chinese adults. Hypertension. 2019;73:893–9.
pubmed: 30776974
doi: 10.1161/HYPERTENSIONAHA.118.12396
Zheng M, Xu X, Wang X, Huo Y, Xu X, Qin X, et al. Age, arterial stiffness, and components of blood pressure in Chinese adults. Medicine. 2014;93:e262.
pubmed: 25546666
pmcid: 4602627
doi: 10.1097/MD.0000000000000262
Rockwood MR, Howlett SE. Blood pressure in relation to age and frailty. Can Geriatrics J. 2011;14:2.
doi: 10.5770/cgj.v14i1.1
Franklin SS. Ageing and hypertension: the assessment of blood pressure indices in predicting coronary heart disease. J Hypertens Suppl. 1999;17:S29–36.
pubmed: 10706323
Gu Q, Burt VL, Paulose-Ram R, Dillon CF. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999–2004. Am J Hypertens. 2008;21:789–98.
pubmed: 18451806
doi: 10.1038/ajh.2008.185
Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z, et al. Status of hypertension in china: results from the China Hypertension Survey, 2012-2015. Circulation 2018;137:2344–56.
pubmed: 29449338
doi: 10.1161/CIRCULATIONAHA.117.032380
Ramirez LA, Sullivan JC. Sex differences in hypertension: where we have been and where we are going. Am J Hypertens. 2018;31:1247–54.
pubmed: 30299518
pmcid: 6233684
doi: 10.1093/ajh/hpy148
Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA. 2005;294:466–72.
pubmed: 16046653
doi: 10.1001/jama.294.4.466
Zhang Y, Moran AE. Trends in the prevalence, awareness, treatment, and control of hypertension among young adults in the United States, 1999 to 2014. Hypertension. 2017;70:736–42.
pubmed: 28847890
doi: 10.1161/HYPERTENSIONAHA.117.09801
Guo X, Zou L, Zhang X, Li J, Zheng L, Sun Z, et al. Prehypertension: a meta-analysis of the epidemiology, risk factors, and predictors of progression. Tex Heart Inst J. 2011;38:643–52.
pubmed: 22199424
pmcid: 3233334
Ndzie Noah ML, Adzika GK, Mprah R, Adekunle AO, Adu-Amankwaah J, Sun H. Sex-gender disparities in cardiovascular diseases: the effects of estrogen on eNOS, lipid profile, and NFATs during catecholamine stress. Front Cardiovasc Med. 2021;8:639946.
pubmed: 33644139
pmcid: 7907444
doi: 10.3389/fcvm.2021.639946
Shankar A, Klein BE, Klein R. Relationship between white blood cell count and incident hypertension. Am J Hypertens. 2004;17:233–9.
pubmed: 15001197
doi: 10.1016/j.amjhyper.2003.11.005
Friedman GD, Selby JV, Quesenberry CP Jr. The leukocyte count: a predictor of hypertension. J Clin Epidemiol. 1990;43:907–11.
pubmed: 2213079
doi: 10.1016/0895-4356(90)90074-Y
Idler EL, Angel RJ. Self-rated health and mortality in the NHANES-I Epidemiologic Follow-up Study. Am J Public Health. 1990;80:446–52.
pubmed: 2316767
pmcid: 1404567
doi: 10.2105/AJPH.80.4.446
Orakzai R, Orakzai S, Nasir K, Santos R, Rana J, Pimentel I, et al. Association of white blood cell count with systolic blood pressure within the normotensive range. J Hum Hypertens. 2006;20:341–7.
pubmed: 16511508
doi: 10.1038/sj.jhh.1001992
Karthikeyan V, Lip G. White blood cell count and hypertension. J Hum Hypertens. 2006;20:310–2.
pubmed: 16437128
doi: 10.1038/sj.jhh.1001980
Curiati MNC, Silvestre OM, Pires LJT, Mangini S, Pires PV, Gaiotto FA, et al. Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables. Einstein. 2013;11:273–7.
pubmed: 24136751
pmcid: 4878583
doi: 10.1590/S1679-45082013000300003
Cheema AN, Khan DA, Tuyyab F. Early detection of cardiac dysfunction by BNP in beta-thalassaemia major patients. Acta Cardiologica. 2012;67:331–5.
pubmed: 22870742
doi: 10.1080/AC.67.3.2160723
Palazzuoli A, Quatrini I, Calabrò A, Antonelli G, Caputo M, Campagna MS, et al. Anemia correction by erythropoietin reduces BNP levels, hospitalization rate, and NYHA class in patients with cardio-renal anemia syndrome. Clin Exp Med. 2011;11:43–8.
pubmed: 20512394
doi: 10.1007/s10238-010-0100-y
Takeda T, Kohno M. Brain natriuretic peptide in hypertension. Hypertens Res. 1995;18:259–66.
pubmed: 8747303
doi: 10.1291/hypres.18.259
Casserly B, Klinger JR. Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent. Drug Des Dev Ther. 2009;3:269.
Jae SY, Kurl S, Laukkanen JA, Heffernan KS, Choo J, Choi Y-H, et al. Higher blood hematocrit predicts hypertension in men. J Hypertens. 2014;32:245–50.
pubmed: 24248088
doi: 10.1097/HJH.0000000000000029
Tripolino C, Gnasso A, Carallo C, Scavelli FB, Irace C. Hemorheological profiles of subjects with prehypertension. Hypertens Res. 2016;39:519–23.
pubmed: 26911233
doi: 10.1038/hr.2016.20
Divya R, Ashok V. A study of hematological parameters and anthropometric indicators in hypertensive and normotensive males. Int J Curr Res Rev. 2016;8:6.
Babu KR, Solepure A, Shaikh R. Comparison of hematological parameters in primary hypertensives and normotensives of sangareddy. Int J Biomed Res. 2015;6:309–15.
doi: 10.7439/ijbr.v6i5.1994
Karabulut A, Karadag A. Clinical implication of hematological indices in the essential hypertension. World J Hypertens. 2015;5:93–7.
doi: 10.5494/wjh.v5.i2.93
Cirillo M, Laurenzi M, Trevisan M, Stamler J. Hematocrit, blood pressure, and hypertension. The Gubbio Population Study. Hypertension. 1992;20:319–26.
pubmed: 1516951
doi: 10.1161/01.HYP.20.3.319
Al-Muhana F, Larbi E, Al-Ali A, Al-Sultan A, Al-Ateeeq S, Soweilem L, et al. Haematological, lipid profile and other biochemical parameters in normal and hypertensive subjects among the population of the eastern province of Saudi Arabia. East Afr Med J. 2006;83:44–8.
pubmed: 16642750
Ighoroje A, Dapper D. Sex variations in the haemorheological parameters of some hypertensive Nigerians as compared to hypertensive. Niger J Physiological Sci. 2005;20:33–8.
Bruschi G, Minari M, Bruschi ME, Tacinelli L, Milani B, Cavatorta A, et al. Similarities of essential and spontaneous hypertension. Volume and number of blood cells. Hypertension. 1986;8:983–9.
pubmed: 3770873
doi: 10.1161/01.HYP.8.11.983
Postnov YV, Kravtsov GM, Orlov S, Pokudin N, Postnov IY, Kotelevtsev YV. Effect of protein kinase C activation on cytoskeleton and cation transport in human erythrocytes. Reproduction of some membrane abnormalities revealed in essential hypertension. Hypertension. 1988;12:267–73.
pubmed: 3169942
doi: 10.1161/01.HYP.12.3.267
Sharp DS, Curb JD, Schatz IJ, Meiselman HJ, Fisher TC, Burchfiel CM, et al. Mean red cell volume as a correlate of blood pressure. Circulation. 1996;93:1677–84.
pubmed: 8653873
doi: 10.1161/01.CIR.93.9.1677
Enawgaw B, Adane N, Terefe B, Asrie F, Melku M. A comparative cross-sectional study of some hematological parameters of hypertensive and normotensive individuals at the university of Gondar hospital, Northwest Ethiopia. BMC Hematol. 2017;17:1–7.
doi: 10.1186/s12878-017-0093-9
Gunebakmaz O, Kaya MG, Duran M, Akpek M, Elcik D, Eryol NK. Red blood cell distribution width in ‘non-dippers’ versus ‘dippers’. Cardiology. 2012;123:154–9.
pubmed: 23128599
doi: 10.1159/000342667
Enawgaw B, Adane N, Terefe B, Asrie F, Melku M. A comparative cross-sectional study of some hematological parameters of hypertensive and normotensive individuals at the university of Gondar hospital, Northwest Ethiopia. BMC Hematol. 2017;17:21.
pubmed: 29209503
pmcid: 5704458
doi: 10.1186/s12878-017-0093-9
Sileshi B, Urgessa F, Wordofa M. A comparative study of hematological parameters between hypertensive and normotensive individuals in Harar, eastern Ethiopia. PLoS One. 2021;16:e0260751.
pubmed: 34874952
pmcid: 8651120
doi: 10.1371/journal.pone.0260751
Li N, Zhou H, Tang Q. Red blood cell distribution width: a novel predictive indicator for cardiovascular and cerebrovascular diseases. Dis Markers. 2017;2017:7089493.
pubmed: 29038615
pmcid: 5606102
doi: 10.1155/2017/7089493
Fornal M, Wizner B, Cwynar M, Królczyk J, Kwater A, Korbut RA, et al. Association of red blood cell distribution width, inflammation markers and morphological as well as rheological erythrocyte parameters with target organ damage in hypertension. Clin Hemorheol Microcirc. 2014;56:325–35.
pubmed: 23719424
doi: 10.3233/CH-131745
Farhangi MA, Keshavarz S-A, Eshraghian M, Ostadrahimi A, Saboor-Yaraghi A-A. White blood cell count in women: relation to inflammatory biomarkers, haematological profiles, visceral adiposity, and other cardiovascular risk factors. J Health Popul Nutr. 2013;31:58.
pubmed: 23617205
pmcid: 3702359
doi: 10.3329/jhpn.v31i1.14749
Ozcan F, Turak O, Durak A, Işleyen A, Uçar F, Giniş Z, et al. Red cell distribution width and inflammation in patients with non-dipper hypertension. Blood Press. 2013;22:80–5.
pubmed: 22835009
doi: 10.3109/08037051.2012.707336
Abul Y, Ozsu S, Korkmaz A, Bulbul Y, Orem A, Ozlu T. Red cell distribution width: a new predictor for chronic thromboembolic pulmonary hypertension after pulmonary embolism. Chron Respir Dis. 2014;11:73–81.
pubmed: 24595892
doi: 10.1177/1479972314525057
Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008;117:163–8.
pubmed: 18172029
doi: 10.1161/CIRCULATIONAHA.107.727545
Ates I, Bulut M, Ozkayar N, Dede F. Association between high platelet indices and proteinuria in patients with hypertension. Ann Lab Med. 2015;35:630–4.
pubmed: 26354352
pmcid: 4579108
doi: 10.3343/alm.2015.35.6.630
Lande K, Os I, Kjeldsen SE, Westheim A, Hjermann I, Eide I, et al. Increased platelet size and release reaction in essential hypertension. J Hypertens. 1987;5:401–6.
pubmed: 2959720
doi: 10.1097/00004872-198708000-00003
Yaghoubi A, Golmohamadi Z, Alizadehasl A, Azarfarin R. Role of platelet parameters and haematological indices in myocardial infarction and unstable angina. J Pak Med Assoc. 2013;63:1133–7.
pubmed: 24601192
Lee KW, Blann AD, Lip GY. High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: relationship to thrombogenesis and endothelial damage/dysfunction. Am J Hypertens. 2005;18:104–15.
pubmed: 15691624
doi: 10.1016/j.amjhyper.2004.09.003
Boos CJ, Beevers GD, Lip GY. Assessment of platelet activation indices using the ADVIATM 120 amongst ‘high‐risk’patients with hypertension. Ann Med. 2007;39:72–8.
pubmed: 17364453
doi: 10.1080/07853890601040063
Bae MH, Lee JH, Yang DH, Park HS, Cho Y, Chae SC. White blood cell, hemoglobin and platelet distribution width as short-term prognostic markers in patients with acute myocardial infarction. J Korean Med Sci. 2014;29:519–26.
pubmed: 24753699
pmcid: 3991795
doi: 10.3346/jkms.2014.29.4.519
Bekler A, Ozkan MTA, Tenekecioglu E, Gazi E, Yener AU, Temiz A, et al. Increased platelet distribution width is associated with severity of coronary artery disease in patients with acute coronary syndrome. Angiology. 2015;66:638–43.
pubmed: 25112777
doi: 10.1177/0003319714545779
Varol E, Akcay S, Icli A, Yucel H, Ozkan E, Erdogan D, et al. Mean platelet volume in patients with prehypertension and hypertension. Clin Hemorheol Microcirc. 2010;45:67–72.
pubmed: 20571231
doi: 10.3233/CH-2010-1327
Leow MK-S. Environmental origins of hypertension: phylogeny, ontogeny and epigenetics. Hypertens Res. 2015;38:299–307.
pubmed: 25693856
doi: 10.1038/hr.2015.7
Siebers R, Maling T. Mean platelet volume in human essential hypertension. J Hum Hypertens. 1995;9:207.
pubmed: 7783106
Ahmadzadeh J, Mansorian B, Attari MM-A, Mohebbi I, Naz-Avar R, Moghadam K, et al. The association between hematological parameters and metabolic syndrome in Iranian men: a single center large-scale study. Diabetes Metab Syndrome Clin Res Rev. 2018;12:17–21.
doi: 10.1016/j.dsx.2017.07.044
Chul Sung K, Suh JY, Kim BS, Kang JH, Kim H, Lee MH, et al. High sensitivity C-reactive protein as an independent risk factor for essential hypertension. Am J Hypertens. 2003;16:429–33.
doi: 10.1016/S0895-7061(03)00566-1
Fujii M, Ohnishi H, Saitoh S, Akasaka H, Miura T, Mori M. The combination of abdominal obesity and high-sensitivity C-reactive protein predicts new-onset hypertension in the general Japanese population: the Tanno–Sobetsu study. Hypertens Res. 2015;38:426–32.
pubmed: 25787035
doi: 10.1038/hr.2015.27
Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of developing hypertension. JAMA. 2003;290:2945–51.
pubmed: 14665655
doi: 10.1001/jama.290.22.2945
Tangvarasittichai S, Pingmuanglaew P, Tangvarasittichai O. Association of Elevated Serum Lipoprotein (a), inflammation, oxidative stress and chronic kidney disease with hypertension in non-diabetes hypertensive patients. Indian J Clin Biochem. 2016;31:446–51.
pubmed: 27605742
pmcid: 4992491
doi: 10.1007/s12291-016-0553-1
Niskanen L, Laaksonen DE, Nyyssönen K, Punnonen K, Valkonen V-P, Fuentes R, et al. Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension. 2004;44:859–65.
pubmed: 15492131
doi: 10.1161/01.HYP.0000146691.51307.84
Verma S, Wang C-H, Li S-H, Dumont AS, Fedak PW, Badiwala MV, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 2002;106:913–9.
pubmed: 12186793
doi: 10.1161/01.CIR.0000029802.88087.5E
Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation. 2002;106:1439–41.
pubmed: 12234944
doi: 10.1161/01.CIR.0000033116.22237.F9
Devaraj S, Xu DY, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation. 2003;107:398–404.
pubmed: 12551862
doi: 10.1161/01.CIR.0000052617.91920.FD